Radiolabelled somatostatin analogs for diagnosis and radio-guided surgery of neuroendocrine breast cancer undetectable with conventional imaging procedures

Breast

Volumn 17, Issue 1, 2008, Pages 111-114

  Panareo, S ^a   Carcoforo, P ^b   Lanzara, S ^b   Corcione, S ^a   Bagatin, E ^a   Casali, M ^a   Costanzo, A ^a   Basaglia, E ^b   Feggi, L M ^a  

^a UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Breast magnetic resonance; Breast neuroendocrine tumour; In 111 pentetreotide; Radio guided surgery; SPECT

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; CA 15.3 ANTIGEN; CA 19.9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN A; NEURON SPECIFIC ENOLASE; PENTETREOTIDE IN 111; SOMATOSTATIN DERIVATIVE; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ABDOMEN; ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST RECONSTRUCTION; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INFILTRATION; CANCER LOCALIZATION; CARCINOMA IN SITU; CASE REPORT; ECHOGRAPHY; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; ISOTOPE LABELING; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MASTECTOMY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RADIOSURGERY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX; WHOLE BODY SCINTISCANNING;

EID: 38949135744     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.08.002     Document Type: Article

References (31)

1. Creutzfeldt W. Carcinoid tumours: development of our knowledge. World J Surg 20 (1996) 126-131
2. Reubi J.C., and Maurer R. Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary. Neuroscience 15 (1985) 1183-1193
3. Patel Y.C., Amherdt M., and Orci L. Quantitative electronic microscopic autoradiography of insulin, glucagon and somatostatin binding sites on islets. Science 217 (1982) 1155-1156
4. Ouazzani L., Reubi J.C., Volle G.E., et al. Evaluation of somatostatin biosynthesis, receptors and tumor growth in murine medullary thyroid carcinoma. Eur J Endocrinol 131 (1994) 522-530
5. Maluf H.M., and Koerner F.C. Carcinomas of the breast with endocrine differentiation: a review. Virchows Arch 425 (1994) 449-457
6. Odiel D., and Meena B. Diffuse neuroendocrine differentiation in a morphologically composite mammary infiltrating ductal carcinoma. Arch Pathol Lab Med 127 (2003) 131-134
7. Seregni E., Ferrari L., Stivanello M., et al. Laboratory tests for neuroendocrine tumors. Q J Nucl Med 44 (2000) 22-41
8. Rosen P.P. Mammary carcinomas with endocrine features. In: Rosen P.P. (Ed). Breast pathology (1997), Lippincott-Raven, Philadelphia 431-435
9. Papotti M., Macri L., Finzi G., et al. Neuroendocrine differentiation in carcinoma of the breast: a study of 51 cases. Semin Diagn Pathol 61 (1989) 174-188
10. Lesser M.L., Rosen P.P., and Kinne D.W. Multicentricity and bilaterality in invasive breast carcinoma. Surgery 1 (1982) 234-240
11. Newman W. Lobular carcinoma of the female breast. Report of 73 cases. Ann Surg 164 (1966) 305-314
12. Fechner R.E. Infiltrating lobular carcinoma without lobular carcinoma in situ. Cancer 29 (1972) 1539-1545
13. Di Costanzo D., Rosen P.P., Gareen I., et al. Prognosis in infiltrating lobular carcinoma. An analysis of "classical" and variant tumors. Am J Surg Pathol 14 (1990) 12-23
14. Richter G.O., Dockerty M.B., and Clagett O.T. Diffuse infiltrating scirrhous carcinoma of the breast. Special consideration of the single-filing phenomenon. Cancer 20 (1967) 363-370
15. Shousha S., Backhous C.M., Alaghband-Zadeh J., et al. Alveolar variant of invasive lobular carcinoma of the breast. Am J Clin Pathol 85 (1986) 1-5
16. Sapino A., Righi L., Cassoni P., et al. Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol 17 (2000) 127-137
17. Papotti M., Gherardi G., Eusebi V., et al. Primary oat cell (neuroendocrine) carcinoma of the breast. Virchows Arch A 420 (1992) 103-108
18. Miremadi A., Pinder S.E., Lee A.H., et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology 40 (2002) 215-222
19. Sapino A., Righi L., Cassoni P., Papotti M., Pietribasi F., and Bussolati G. Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol 17 (2000) 127-137
20. Zekioglu O., Erhan Y., Ciris M., and Bayramoglu H. Neuroendocrine differentiated carcinomas of the breast: a distinct entity. Breast 12 (2003) 251-257
21. Sapino A., Papotti M., Righi L., Cassoni P., Chiusa L., and Bussolati G. Clinical significance of neuroendocrine carcinoma of the breast. Ann Oncol 12 Suppl. 2 (2001) 115-117
22. Berruti A., Saini A., Leonardo E., Cappia S., Borasio P., and Dogliotti L. Management of neuroendocrine differentiated breast carcinoma. Breast 13 (2004) 527-529
23. Tsang W.Y.W., and Chan J.K.C. Endocrine ductal carcinoma in situ (E-DCIS) of the breast. Am J Surg Pathol 20 (1996) 921-943
24. Mccarthy K.E., Woltering E.A., and Anthony L.B. In situ radiotherapy with 111In-pentetreotide. State of the art and perspectives. Q J Nucl Med 44 (2000) 88-95
25. Adams S., and Baum R.P. Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors. Q J Nucl Med 44 (2000) 59-67
26. Gennari R., Galimberti V., De Cicco C., et al. Use of technetium-99m-labelled colloid albumin for preoperative and intraoperative localisation of occult breast lesions. J Am Coll Surg 190 (2000) 692-699
27. Zurrida S., Galimberti V., Monti S., et al. Radioguided localisation of occult breast lesions. Breast 7 (1998) 11-13
28. De Cicco C., Pizzamiglio M., Trifiro G., et al. Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer-technical aspects. Q J Nucl Med 46 (2002) 145-151
29. Feggi L.M., Basaglia E., Corcione S., et al. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation. Eur J Nucl Med 28 (2001) 1589-1596
30. Feggi L.M., Querzoli P., Prandini N., et al. Sentinel node study in early breast cancer. Tumori 86 (2000) 314-316
31. Carcoforo P., Feggi L.M., Sartori A., et al. Lymphatic mapping for the dissection of the sentinel node in the treatment of breast carcinoma. Exp Clin Cancer Res 22 (1999) 478-482